These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3260470)

  • 1. Rapid occurrence of nodular cutaneous T-lymphocyte infiltrates with cyclosporine therapy.
    Brown MD; Ellis CN; Billings J; Cooper KD; Baadsgaard O; Headington JT; Voorhees JJ
    Arch Dermatol; 1988 Jul; 124(7):1097-100. PubMed ID: 3260470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytic infiltrates of the skin in association with cyclosporine therapy.
    Gupta AK; Cooper KD; Ellis CN; Nickoloff BJ; Hanson CA; Brown MD; Voorhees JJ
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1137-41. PubMed ID: 2273115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatologic applications of cyclosporine.
    Biren CA; Barr RJ
    Arch Dermatol; 1986 Sep; 122(9):1028-32. PubMed ID: 3527076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced papular eruption following treatment of psoriasis.
    Mebazaa A; Kenani N; Denguezli M; Ben Salem C; Ziadi S; Sriha B; Belajouza C; Nouira R
    Ann Pharmacother; 2008 Jan; 42(1):138-41. PubMed ID: 18094347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporin in dermatology].
    Salomon D; Halioua B
    Schweiz Rundsch Med Prax; 1990 Oct; 79(42):1258-61. PubMed ID: 2237060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis.
    Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):72-7. PubMed ID: 3260052
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of cyclosporine treatment in severe psoriasis: a clinical and immunologic study.
    Finzi AF; Mozzanica N; Cattaneo A; Chiappino G; Pigatto PD
    J Am Acad Dermatol; 1989 Jul; 21(1):91-7. PubMed ID: 2787338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs for dermatologic diseases.
    Landow RK
    Dermatol Clin; 1988 Oct; 6(4):575-84. PubMed ID: 3067917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in lamellar ichthyosis.
    Ho VC; Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Voorhees JJ
    Arch Dermatol; 1989 Apr; 125(4):511-4. PubMed ID: 2649010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A in psoriasis: an immunohistological study.
    Mozzanica N; Cattaneo A; Pigatto PD; Finzi AF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):78-84. PubMed ID: 3260053
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine improves psoriasis in a double-blind study.
    Ellis CN; Gorsulowsky DC; Hamilton TA; Billings JK; Brown MD; Headington JT; Cooper KD; Baadsgaard O; Duell EA; Annesley TM
    JAMA; 1986 Dec; 256(22):3110-6. PubMed ID: 3023712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant severe psoriasis controlled with systemic cyclosporine therapy.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):58-62. PubMed ID: 3381303
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose cyclosporine A in severe psoriasis.
    Marks J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.
    Di Nuzzo S; Zanni M; De Panfilis G
    J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in the treatment of psoriasis.
    Wentzell JM; Baughman RD; O'Connor GT; Bernier GM
    Arch Dermatol; 1987 Feb; 123(2):163-5. PubMed ID: 3813586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous lesions due to lithium therapy (author's transl)].
    Lambert D; Beer F; Gisselman R; Bouilly D; Chapuis JL
    Ann Dermatol Venereol; 1982; 109(1):19-24. PubMed ID: 6462094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of psoriasis-arthritis with cyclosporin A, a new immunosuppressive agent].
    Müller W; Graf U
    Schweiz Med Wochenschr; 1981 Mar; 111(12):408-13. PubMed ID: 7221517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
    Kokelj F; Plozzer C; Torsello P; Trevisan G
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
    Piskin G; Heydendael VM; de Rie MA; Bos JD; Teunissen MB
    Arch Dermatol Res; 2003 Mar; 294(12):559-62. PubMed ID: 12624782
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
    Behnam SM; Behnam SE; Koo JY
    J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.